FDA Approves First Treatment for Pediatric MS
- FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients. US Food and Drug Administration. Accessed May 13, 2018.
- Pediatric MS. National Multiple Sclerosis Society. https://www.nationalmssociety.org/What-is-MS/Who-Gets-MS/Pediatric-MS. Accessed May 13, 2018.
- Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis. Arch Neurol. 2009;66(1):54–59. doi:10.1001/archneurol.2008.505
- Harding KE, Liang K, Cossburn MD, et al. Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. J Neurol Neurosurg Psychiatry Published Online First: 15 November 2012. doi:10.1136/jnnp-2012-303996